Key benefits Why people compare it 1 22.5% mean body weight reduction at 15mg in SURMOUNT-1 (N=2,539, 72 weeks) 2 Dual GIP/GLP-1 receptor activation for combined metabolic effects beyond single-agonist therapy 3 63% of participants at highest dose achieved at least 20% weight loss vs 1.3% placebo 4 Superior A1C reduction of 2.07-2.59% with up to 97% of diabetic participants reaching target 5 Outperformed semaglutide 1mg head-to-head in SURPASS-2 for both weight and glycemic endpoints 6 Enhanced adipose tissue lipid handling and fat redistribution via GIPR signaling 7 Significant improvements in triglycerides, blood pressure, and waist circumference across all doses 8 Once-weekly dosing supported by 120-hour half-life and C20 fatty diacid albumin binding Deep research Tirzepatide is a 39-amino-acid synthetic peptide with a molecular weight of 4,813.45 Da
While thats the lowest astaxanthin dose in this guide, its delivery in krill oil may make it more efficient
Collectively, these agents converge on the Nrf2, SIRT1, and AMPK signaling networks to restore redox homeostasis, prevent mitochondrial dysfunction, and inhibit oxidative stressinduced apoptosis, ultimately improving follicular viability and oocyte developmental competence during cryopreservation and transplantation
As noted by Dr
Studies comparing GHK (apo) vs GHK-Cu consistently show reduced activity for the copper-free peptide
